Every cancer journey is different. The commonality is that it impacts more than the patient – it affects the patient's family and friends. In this powerful video, Michael and his family share their experience of living with advanced prostate cancer and how radioligand therapy brought renewed hope when a new treatment option was needed. At Curium, we're committed to advancing precision nuclear medicine to help make a meaningful difference for patients and their families. Thank you, Michael, for sharing your inspiring story. #Curium #RadioligandTherapy #NuclearMedicine #ProstateCancer #PatientStories #Oncology
Curium Pharma
Pharmaceutical Manufacturing
Boston, Massachusetts 77,265 followers
Driving innovation in nuclear medicine to improve patients’ lives
About us
Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world. We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potential for new innovation. We build on remarkable foundations and a legacy of providing reliable and consistent nuclear solutions to tens of thousands of patients every day. Our proven heritage combined with a pioneering approach are the hallmarks from which we provide life-changing diagnostics and therapeutics. Our people are the root of the incredible impact they have. As part of our 2030 vision to become an oncology-focused nuclear medicine leader – both in diagnostics and therapy – we will expand our reach further into Japan and China, continuing to roll out our superior products to a global market. The impact of these investments on patients will be life changing. Our cancer focus is currently in Neuroendocrine Tumors (NETs) and prostate cancer PSMA. We are also working on leveraging the power of AI to improve image quality and accuracy; to identify patterns to help diagnose pathologies and of course to better support physicians. Our Promise We strive to make the impossible possible and to be an organization that will change the face of medicine. Our diverse group of industry experts is unified under one strong and singular focus – to develop, manufacture and supply revolutionary diagnostic and therapeutic radiopharmaceuticals to our customers around the globe with unrivaled reliability and superior service.
- Website
-
http://curiumpharma.com/
External link for Curium Pharma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Nuclear Medicine, PET Imaging, Molecular Imaging, cGMP Manufacturing , Contract Manufacturing, and SPECT Imaging
Locations
Employees at Curium Pharma
Updates
-
Curium’s UK & Ireland team win at the Swansea 70.3 Triathlon! 🏊🚴🏃 We're proud to share that our Curium Prostate 2 relay team featuring Simon Martin, kathryn thomas, and Oliver Neil, finished in 1st place! Together with our NHS colleagues, our two relay teams took on the challenge to raise funds for CHAPS (https://chaps-uk.org/) , supporting a national prostate cancer screening programme. A huge thank you to everyone who has supported us so far. There's still time to donate – every contribution helps support this important cause and raises awareness of prostate cancer. https://lnkd.in/eGVRd7Em #Triathlon #TeamCurium #ProstateCancer #ProstateCancerAwareness #EarlyDetection #CancerAwareness #Fundraising #Healthcare #NHS #MakingADifference #Community #Teamwork
-
-
For Oliver Neil, every day at Curium is driven by one purpose: improving patients’ lives As Site Lead in Oxford, his work is very varied and ranges from the launch of PYLCLARI® in the UK to helping deliver an urgent tracer for a newborn baby. His work reflects the real impact our teams make every day for patients. "Behind every dose is a person depending on us. That's something I carry with me every day." Thank you, Oliver, for your dedication and for living Curium's commitment to patients, quality, and innovation. Learn more about Curium careers: https://lnkd.in/dG_PztiU #EmployeeSpotlight #LifeAtCurium #PatientCare #NuclearMedicine #TeamCurium
-
-
We're looking forward to the 45th Annual Meeting of the Bavarian Society of Nuclear Medicine (BGN) this weekend in Garmisch-Partenkirchen. Curium is pleased to host a symposium on Saturday, 11 July, bringing together leading experts to discuss how clinical evidence is advancing the implementation of radioligand therapy in everyday practice. We look forward to connecting with colleagues, exchanging ideas, and contributing to the future of nuclear medicine. See you at BGN 2026! Prof. Marcus Unterrainer, PD Dr. med. Isabel Rauscher, Prof. Wolfgang Weber #BGN2026 #NuclearMedicine #RadioligandTherapy #Theranostics #Curium
-
-
Today’s employee spotlight: Carole Chahal Cheminel, network quality director & QP PET France Since joining Curium in 2017, Carole has grown into a leadership role while helping strengthen quality across our network—all driven by a shared purpose: improving cancer care for patients. For Carole, Curium is a place where people are supported to grow. Her own career progression, including during maternity leave, reflects our commitment to equal opportunities and an inclusive culture. Thank you, Carole, for your dedication and impact every day. Learn more about Curium’s careers: https://lnkd.in/dG_PztiU #TodaysEmployeeSpotlight #TeamCurium #LifeAtCurium #Leadership #Quality #EmployeeSpotlight
-
-
The Curium Women's Network North America recently hosted a Lunch & Networking Event featuring Curium leadership and Kate Briant, Founding Partner, CapVest and Chair, Curium Group. The session brought colleagues together to share experiences, build connections, and strengthen our community. Thank you to everyone who joined and contributed to the conversation. #Curium #LifeAtCurium #WomenInLeadership #CuriumWomensNetwork #Networking #Inclusion #NorthAmerica
-
-
Every breakthrough begins with a story. Our new corporate video brings together the voices of patients, healthcare professionals, and Curium colleagues to showcase the impact of nuclear medicine and the purpose that drives us every day. Together, we're advancing innovation to improve lives today, and for generations to come. #Curium #NuclearMedicine #HealthcareInnovation #PatientCare #Oncology #Radiopharmaceuticals
-
More than 250 colleagues and their families took part in this year's St. Louis Triathlon, coming together to take on the cycling and running events with determination, resilience, and team spirit. Congratulations to everyone who participated, and a special shoutout to our medal winners! This event is a great reminder of what our values look like in action: Aim High. Win as One. Never Give Up. #Curium #STLTriathlon #TeamCurium #AimHigh #WinAsOne #NeverGiveUp
-
-
Curium Pharma reposted this
We’re honored to feature Renaud. Dehareng, CEO of Curium Pharma , in our latest spotlight on visionary leaders advancing the future of healthcare through innovation, precision medicine, and patient-centered leadership. As the leader of one of the world’s foremost nuclear medicine organizations, Renaud is helping shape a new era in healthcare where advanced diagnostics and targeted therapies work together to improve patient outcomes. His strategic vision, operational excellence, and commitment to innovation have positioned Curium at the forefront of the rapidly evolving field of theranostics and radiopharmaceutical medicine. Under his leadership, Curium continues to expand its global footprint, reaching millions of patients across more than 70 countries while investing in next-generation oncology solutions that are transforming cancer care. Renaud’s approach combines bold ambition with disciplined execution, ensuring that groundbreaking innovations not only reach the market but also reach patients when they need them most. What truly sets Renaud apart is his unwavering belief that healthcare innovation should always serve a greater purpose. By fostering collaboration, empowering experts, and building resilient global operations, he is helping create a future where precision medicine becomes more accessible, reliable, and impactful for patients worldwide. Full Article: https://lnkd.in/gQhADK8k Digital Edition: https://lnkd.in/gg7m5nfa #RenaudDehareng #CuriumGroup #Leadership #HealthcareInnovation #PrecisionMedicine #NuclearMedicine #Oncology #PatientCare #LifeSciences #MedicalInnovation #BusinessLeadership #Curium #StrategicLeadership #CEO #Healthcare #GlobalHealthcare #HealthcareTransformation #Innovation #FutureOfHealthcare #Timeiconic
-
-
-
-
-
+3
-
-
Our new Oxford facility is officially open! This important milestone follows the award of Manufacturing Import Authorisation (MIA) from the MHRA for PYLCLARI® in Oxford. This means that we are now able to expand access to licensed prostate cancer diagnostics in the UK and reflects Curium's continued investment in healthcare innovation and patient care. Ciril Faia, CEO of Curium International welcomed Lord Mayor of Oxford, Councillor Chewe Munkonge, and Lady Mayoress Carol Munkonge, alongside Professor Sabina Dizdarevic, President of the British Nuclear Medicine Society (BNMS), Dr Amy Eccles, Honorary Secretary of BNMS, Jilly Croasdale of University Hospitals Birmingham NHS Foundation Trust and former BNMS President.
-